D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
Starbucks
SBUX
|
+$370M |
| 3 |
Pfizer
PFE
|
+$338M |
| 4 |
PayPal
PYPL
|
+$320M |
| 5 |
Charles Schwab
SCHW
|
+$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$415M |
| 4 |
Citigroup
C
|
+$312M |
| 5 |
Booking.com
BKNG
|
+$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VWEWW
2401
DELISTED
Vintage Wine Estates, Inc. Warrants
VWEWW
| $1.66M | ﹤0.01% |
+850,000
| New | +$1.66M |
|
2402
Lakeland Financial Corp
LKFN
$1.63B
| $1.65M | ﹤0.01% |
+22,583
| New | +$1.65M |
|
2403
Dorian LPG
LPG
$1.38B
| $1.65M | ﹤0.01% |
113,808
-111,250
| -49% | -$1.61M |
|
2404
Cassava Sciences
SAVA
$101M
| $1.65M | ﹤0.01% |
+44,400
| New | +$1.65M |
|
|
HR
2405
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.65M | ﹤0.01% |
60,020
-144,944
| -71% | -$3.98M |
|
2406
Y-mAbs Therapeutics
YMAB
$391M
| $1.65M | ﹤0.01% |
+138,657
| New | +$1.65M |
|
2407
Global Ship Lease
GSL
$1.14B
| $1.65M | ﹤0.01% |
+57,739
| New | +$1.65M |
|
2408
Insight Enterprises
NSIT
$3.79B
| $1.64M | ﹤0.01% |
15,315
+9,665
| +171% | +$1.04M |
|
|
OMIC
2409
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $1.64M | ﹤0.01% |
8,680
+6,821
| +367% | +$1.29M |
|
2410
National Bank Holdings
NBHC
$1.43B
| $1.64M | ﹤0.01% |
40,646
+32,560
| +403% | +$1.31M |
|
2411
NVR
NVR
$22.7B
| $1.64M | ﹤0.01% |
366
+173
| +90% | +$773K |
|
2412
Lyell Immunopharma
LYEL
$254M
| $1.63M | ﹤0.01% |
16,162
+8,058
| +99% | +$814K |
|
|
CMRC
2413
Commerce.com, Inc. Series 1 Common Stock
CMRC
$395M
| $1.63M | ﹤0.01% |
74,258
-239,328
| -76% | -$5.24M |
|
|
SCAQ
2414
DELISTED
Stratim Cloud Acquisition Corp. Class A Common Stock
SCAQ
| $1.63M | ﹤0.01% |
166,530
-379,199
| -69% | -$3.7M |
|
2415
Weis Markets
WMK
$1.78B
| $1.62M | ﹤0.01% |
22,728
+3,101
| +16% | +$221K |
|
2416
ABM Industries
ABM
$2.74B
| $1.62M | ﹤0.01% |
35,245
-79,753
| -69% | -$3.67M |
|
|
SKYA
2417
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
| $1.62M | ﹤0.01% |
166,559
-397,450
| -70% | -$3.87M |
|
2418
Penske Automotive Group
PAG
$11.8B
| $1.62M | ﹤0.01% |
17,232
+7,011
| +69% | +$657K |
|
|
AGTI
2419
DELISTED
Agiliti, Inc.
AGTI
| $1.62M | ﹤0.01% |
76,504
+14,491
| +23% | +$306K |
|
|
MTOR
2420
DELISTED
MERITOR, Inc.
MTOR
| $1.62M | ﹤0.01% |
45,410
-312,858
| -87% | -$11.1M |
|
2421
SunCoke Energy
SXC
$670M
| $1.61M | ﹤0.01% |
180,879
-49,513
| -21% | -$441K |
|
2422
Carvana
CVNA
$50.3B
| $1.61M | ﹤0.01% |
13,468
+8,968
| +199% | +$1.07M |
|
2423
Better Home & Finance Holding
BETR
$391M
| $1.61M | ﹤0.01% |
3,255
-529
| -14% | -$261K |
|
|
BSAQ
2424
DELISTED
Black Spade Acquisition Co
BSAQ
| $1.6M | ﹤0.01% |
164,835
-21,771
| -12% | -$211K |
|
2425
Rigel Pharmaceuticals
RIGL
$627M
| $1.6M | ﹤0.01% |
53,373
+45,144
| +549% | +$1.35M |
|